Crowdonomics
All companies
Spinal Surgical Strategies, Inc. logo

Spinal Surgical Strategies, Inc.

Operating

Healthcare · Incline Village, NV

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$2,473,499
Crowd $1.1M · Private $1.4M · 3 rounds since 2013
Latest share price
$3.50
Reg CF · Common Stock · May 2021 offering price

Financials

FY2012–FY2020 (no data for FY2014, FY2015, FY2016, FY2017, FY2018) · from SEC filings · hover any figure for its source
$43K
−$1.6M
2012
$36K
−$1.3M
2013
2014no data
2015no data
2016no data
2017no data
2018no data
$30K
−$785K
2019
$43K
−$1.6M
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2012
FY2013
FY2019 reviewed*
FY2020 reviewed*
Income statement
Revenue
$43,333
$35,899
$29,812
$43,333
Cost of goods sold
$8,454
$3,957
$6,348
$8,454
Gross margin
80%
89%
79%
80%
Net income
-$1,570,970
-$1,291,034
-$784,549
-$1,570,970
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$140,141
$40,075
$173,413
$140,141
Accounts receivable
$6,920
$4,848
$9,531
$6,920
Total assets
$585,816
$968,671
$282,262
$585,816
Short-term debt
$694,592
$1,729,477
$863,509
$694,592
Long-term debt
$6,724
$525
$12,666
$6,724
Total liabilities
$701,316
$1,730,002
$876,175
$701,316
Other
Headcount
—
0
—
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Raised $1.1M / $1.1M
Raised $634KInvestors 22
Raised $769.5KInvestors 20

Team

3 people
/s/ Jeffrey Kleiner
CEO, President and Director
/s/ Harris Kirshner
CFO, Secretary and Director
/s/ Stewart Peabody
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 5 annual reports (FY2021–FY2025)

22 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 29, 20220001213900-22-022684
    EDGAR
  • Form C-UApr 29, 20220001213900-22-022687
    EDGAR
  • Form CMay 5, 20210001213900-21-024698
    EDGAR
  • Form DApr 14, 20210001851942-21-000002
    EDGAR
  • Form DApr 12, 20210001851942-21-000001
    EDGAR
Source: SEC EDGARCIK 0001851942NVShare price $3.50Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.